Recurrent genetic alterations and targeted therapies under investigation in iCCA
Recurrent genetic alterations and targeted therapies under investigation in iCCA. Genetic alterations in tyrosine kinase receptors and downstream RAS/MAPK, PI3K/AKT/mTOR effector casades result in aberrant modulation of proliferation, apoptosis and cell cycle. Newly identified mutations in MAP3K4 lead to EMT process in iCCA through p38/NF-kB signaling pathway. Mutated IDH1/IDH2 result in the accumulation of oncogenic metabolite 2HG. Potential targeted therapies against the above alterations are currently under clinical trials. Recurrently mutated chromatin remodeling genes also present as druggable targets.
Publication
Genetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapy. (2016) Diyang Xie, et al. Am J Cancer Res. 2016;6(3):577-586. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | ROS1 | ROS1 | ncbigene_symbol | ROS1 | 6098 |
| Homo sapiens | Primates | FGFR2 | FGFR2 | ncbigene_symbol | FGFR2 | 2263 |
| Homo sapiens | Primates | C-MET | C-MET | ncbigene_synonym | MET | 4233 |
| Homo sapiens | Primates | EGF | EGF | ncbigene_symbol | EGF | 1950 |
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | IDH1 | IDH1 | ncbigene_symbol | IDH1 | 3417 |
| Homo sapiens | Primates | TAG | TAG | ncbigene_synonym | TMED7 | 51014 |
| Homo sapiens | Primates | TAG | TAG | ncbigene_synonym | LINC01194 | 404663 |
| Homo sapiens | Primates | IDH2 | IDH2 | ncbigene_symbol | IDH2 | 3418 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K/AKT/MTOR | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK1 | 5594 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK14 | 1432 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK8 | 5599 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | RAS/MAPK | MAPK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | RAS/MAPK | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS/MAPK | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS/MAPK | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | MAP3K4/p38 | MAP3K4 | ncbigene_symbol | MAP3K4 | 4216 |
| Homo sapiens | Primates | MAP3K4/p38 | P38 | ncbigene_synonym | CRK | 1398 |
| Homo sapiens | Primates | MAP3K4/p38 | P38 | ncbigene_synonym | AIMP2 | 7965 |
| Homo sapiens | Primates | MAP3K4/p38 | P38 | ncbigene_synonym | GRAP2 | 9402 |
| Homo sapiens | Primates | MAP3K4/p38 | P38 | ncbigene_synonym | AHSA1 | 10598 |
| Homo sapiens | Primates | MAP3K4/p38 | P38 | ncbigene_synonym | POLDIP2 | 26073 |
| Homo sapiens | Primates | PTPN3 | PTPN3 | ncbigene_symbol | PTPN3 | 5774 |
| Homo sapiens | Primates | RAF | RAF | ncbigene_synonym | ZHX2 | 22882 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | ARAF | 369 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | BRAF | 673 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | RAF1 | 5894 |
| Homo sapiens | Primates | TP53,CDK6 | CDK6 | ncbigene_symbol | CDK6 | 1021 |
| Homo sapiens | Primates | TP53,CDK6 | TP53 | ncbigene_symbol | TP53 | 7157 |
| Homo sapiens | Primates | CCND1 | CCND1 | ncbigene_symbol | CCND1 | 595 |
| Homo sapiens | Primates | MEK | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | NF-KB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | ARID1A | ARID1A | ncbigene_symbol | ARID1A | 8289 |
| Homo sapiens | Primates | PRRM1,BAP1 | BAP1 | ncbigene_symbol | BAP1 | 8314 |
| Homo sapiens | Primates | PRRM1,BAP1 | BAP1 | ncbigene_synonym | RNF2 | 6045 |
| Homo sapiens | Primates | PRRM1,BAP1 | BAP1 | ncbigene_synonym | MAGI1 | 9223 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | EMT | EMT | ncbigene_synonym | ITK | 3702 |
| Homo sapiens | Primates | EMT | EMT | ncbigene_synonym | SLC22A3 | 6581 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Cabozantinib | cabozantinib | mesh:C558660 | cabozantinib | chebi:72317 |
| Regorafenib | regorafenib | mesh:C559147 | regorafenib | chebi:68647 |
| Isocitrate | NA | mesh:D007523 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | NA | |||
| Cardiomyopathy | NA | |||
| Cholangiocarcinoma | NA | |||
| Lung cancer | NA | |||
| Melanoma | NA | |||
| Noonan syndrome | NA |